# Antiallergic and Anti-Inflammatory Effects of a Novel IκB Kinase β Inhibitor, IMD-0354, in a Mouse Model of Allergic Inflammation

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/antiallergic-and-anti-inflammatory-effects-of-a-novel-i-b-kinase-inhibitor-imd/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Akemi Sugita,Hirohisa Ogawa,Masahiko Azuma,Susumu Muto,Akifumi Honjo,Hiroaki Yanagawa,Yasuhiko Nishioka,Kenji Tani,Akiko Itai,Saburo Sone |
| Citations | 59 |
| DOI | 10.1159/000161579 |
| Fields | Biochemistry, Genetics and Molecular Biology,Immunology and Microbiology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2075405061 |
| PMID | 18849610 |
| Type | article |
| Year | 2008 |

## Paper authors

- [Hiroaki Yanagawa](https://scholariq.org/researchers/hiroaki-yanagawa/)

## Paper journal

- [International Archives of Allergy and Immunology](https://scholariq.org/journals/international-archives-of-allergy-and-immunology/)

## Paper primary topic

- [NF-κB Signaling Pathways](https://scholariq.org/topics/nf-b-signaling-pathways/)

## Paper topics

- [NF-κB Signaling Pathways](https://scholariq.org/topics/nf-b-signaling-pathways/)
- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.